cardiology-summit-2019-scientifictracks

Page 44

March 25-26, 2019 | Amsterdam, Netherlands

CARDIOLOGY

AND CARDIAC NURSING

World Congress on

Cardiology Summit 2019

Journal of Cardiovascular Medicine and Therapeutics | Volume 3

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

YEARS

Note:

CHRONIC RENAL FAILURE — CARDIOVASCULAR RISK FACTOR

Daniela Loncar

University Clinical Center Tuzla, Bosnia

ardiovascular diseases are a major cause of morbidity and mortality in patients at the end stage of renal

disease. Left ventricular hypertrophy, coronary heart disease and heart failure are the most prevalent cardio-

vascular diseases in dialysis patients. The patients on chronic dialysis have a 10 to 20-fold higher risk of devel-

opment of cardiovascular disease than the general population. The aim of this study is to define the frequency

of risk factors (traditional and non-traditional) for cardiovascular diseases in dialysis patients. The most frequent

traditional factors in this study were hypertension (62%) and hyperlipidemia (60%), while anemia (86%) and

hyperhomocysteinemia (82%) were the most frequent non-traditional factors. To present the study and repeat

again that dialysis patients have high risk of development of cardiovascular disease and this population should

be an ideal target group for primary prevention.

Daniela Loncar, J Cardiovasc Med Ther 2019, Volume 3

Daniela Loncar lives in Tuzla, Bosnia and Herzegovina. She is an internist at the Clinical Center Tuzla, Clinic for Internal

Diseases, ICU. She deals with the noninvasive cardiology with a particular focus of interest in echocardiography. She is

senior assistant on the subject of internal medicine at the Medical school of the University of Tuzla. She is a member of

the Association of Cardiologist of Bosnia and Herzegovina and European Society of Cardiology. She is the autor of papers

and books in the filed of cardiology.

BIOGRAPHY